Arrowhead Pharmaceuticals (ARWR) EBT (2010 - 2026)
Arrowhead Pharmaceuticals (ARWR) posted EBT of -$137.6 million for Q1 2026, down 586.59% on a QoQ basis from $28.3 million in Q4 2025, and down 137.22% year-over-year from $369.6 million in Q1 2025.
Arrowhead Pharmaceuticals (ARWR) EBT (2010 - 2026) Analysis & Trends
Arrowhead Pharmaceuticals' EBT history runs 17 years deep, the most recent figure standing at -$137.6 million for Q1 2026.
- Quarterly EBT fell 137.22% year-over-year to -$137.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$252.3 million (down 65.66% YoY) and the FY2025 annual result came in at $51.5 million, up 108.41% from the prior year.
- EBT was -$137.6 million for Q1 2026 at Arrowhead Pharmaceuticals, down from $28.3 million in the prior quarter.
- Across five years, EBT topped out at $369.6 million in Q1 2025 and bottomed at -$179.1 million in Q2 2025.
- A 5-year average of -$58.0 million and a median of -$103.4 million in 2023 frame the typical range for EBT.
- Annual changes were most pronounced in 2024 — EBT tumbled 366.37% — and 2025, when it jumped 391.05%.
- Arrowhead Pharmaceuticals' EBT stood at -$41.8 million in 2022, then plunged by 231.84% to -$138.7 million in 2023, then fell by 26.26% to -$175.1 million in 2024, then soared by 116.14% to $28.3 million in 2025, then sank by 586.59% to -$137.6 million in 2026.
- Business Quant data shows ARWR's EBT at -$137.6 million in Q1 2026, $28.3 million in Q4 2025, and $36.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.31 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 259.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 438.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Arrowhead Pharmaceuticals | 12.14 Bn | 10.36 Bn | - | -137.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -137.57 Mn |
| Dec 31, 2025 | 28.27 Mn |
| Sep 30, 2025 | 36.12 Mn |
| Jun 30, 2025 | -179.09 Mn |
| Mar 31, 2025 | 369.62 Mn |
| Dec 31, 2024 | -175.12 Mn |
| Sep 30, 2024 | -172.80 Mn |
| Jun 30, 2024 | -173.98 Mn |
| Mar 31, 2024 | -127.00 Mn |
| Dec 31, 2023 | -138.69 Mn |
| Sep 30, 2023 | -108.99 Mn |
| Jun 30, 2023 | -103.38 Mn |
| Mar 31, 2023 | 47.68 Mn |
| Dec 31, 2022 | -41.79 Mn |
| Sep 30, 2022 | -82.16 Mn |
| Jun 30, 2022 | -72.05 Mn |
| Mar 31, 2022 | 44.37 Mn |
| Dec 31, 2021 | -62.87 Mn |
| Sep 30, 2021 | -63.37 Mn |
| Jun 30, 2021 | -29.92 Mn |